Table S2 from CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

2026 Open access

Read full text
Authors: Paul Lin, Sunil Acharya, Francia Reyes-Silva, Rafet Başar, Nadima Uprety, Luz Yurany Moreno Rueda, Pei Lin, April L. Gilbert, Pinaki Prosad Banerjee, Dexing Fang, Chenyu Zhang, Ana Karen Nunez Cortes
+17 more Luciana Melo Garcia, May Daher, Luis Muniz-Feliciano, Gary M. R. Deyter, Vernikka Woods, Seema Rawal, Ping Li, Corry M. Jones, Rejeena Shrestha, Muzaffar H. Qazilbash, Krina K. Patel, Hans Chulhee Lee, Richard E. Champlin, David Marin, Elizabeth J. Shpall, Robert Zygmunt Orlowski, Katayoun Rezvani
DOI: 10.1158/2643-3230.31484149
Cited by: 0

Abstract

Supplementary Table S2. Additional antibodies used for CAR-NK vs CAR-T cell mouse experiments.

Fields of Study & Subjects

CAR-T cell therapy research Multiple Myeloma Research and Treatments Immune Cell Function and Interaction

Publication details

Publication date
4 March 2026
Language
EN